Study site
Dallas, Texas 75390
2 studies enrolling now · 12 studies all time
What they study most
C1 Esterase Inhibitor Deficiency, C1 Esterase Inhibitor [C1-INH] Deficiency, C1 Esterase Inhibitor, Deficiency of, C1 Inhibitor Deficiency, Factor XIII Deficiency, HAE With Normal C1 Esterase Inhibitor, Hereditary Angioedema, Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, Hereditary Angioedema - Type 3, Hereditary Angioedema Attack
Studies at this site
- Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE — Recruiting now
- Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema — Enrolling by invitation
- Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema — Completed
- A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema — Completed
- A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema — Completed
- A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650 — Completed
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes — Completed
- Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus — Completed
- Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks — Completed
- Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy — Completed
- An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency — Completed
- A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency — Completed